NCT01440179 - SAR3419 in Acute Lymphoblastic Leukemia | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Acute Lymphocytic Leukaemia

Interventions

DRUG

SAR3419

Pharmaceutical form: concentrate solution for infusion Route of administration: intravenous

Trial Locations (11)

Investigational Site Number 250002, Pessac

Investigational Site Number 250004, Rennes

Investigational Site Number 840003, Nashville

Investigational Site Number 840004, Milwaukee

Investigational Site Number 250005, Strasbourg

Investigational Site Number 250008, Pierre-Bénite

Investigational Site Number 250001, Paris

Investigational Site Number 840001, Houston

Investigational Site Number 840002, San Antonio

Investigational Site Number 250006, Amiens

Investigational Site Number 840006, Denver